Remnant lipoproteins: are they equal to or more atherogenic than LDL?
CAA Salinas, MJ Chapman - Current Opinion in Lipidology, 2020 - journals.lww.com
CAA Salinas, MJ Chapman
Current Opinion in Lipidology, 2020•journals.lww.comOverall, data from observational studies in large cohorts, Mendelian randomization studies,
meta-regression analyses, and post-hoc analyses of randomized trials are consistent with
the contention that remnants are highly atherogenic particles and contribute to the
atherosclerotic burden in an equivalent manner to that of LDL.
meta-regression analyses, and post-hoc analyses of randomized trials are consistent with
the contention that remnants are highly atherogenic particles and contribute to the
atherosclerotic burden in an equivalent manner to that of LDL.
Summary
Overall, data from observational studies in large cohorts, Mendelian randomization studies, meta-regression analyses, and post-hoc analyses of randomized trials are consistent with the contention that remnants are highly atherogenic particles and contribute to the atherosclerotic burden in an equivalent manner to that of LDL.
Lippincott Williams & Wilkins